The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What are the key biological and clinical characteristics of patients with ultra-low-risk MM?

Jun 29, 2020

During the 25th Congress of the European Hematology Association (EHA), the MM Hub spoke to Mehmet Samur, Dana-Farber Cancer Institute, Boston, US. We asked, What are the key biological and clinical characteristics of patients with ultra-low-risk MM?

What are the key biological and clinical characteristics of patients with ultra-low-risk MM?

Until now, the primary focus of genomic studies in the MM setting has been high-risk disease. Here, Mehmet Samur discusses a study in which patients with newly diagnosed MM underwent whole genome sequencing with the aim to define low-risk patients.